Picture of Optomed Oyj logo

OPTOMED — Optomed Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Optomed Q1 EBITDA Loss Widens To EUR 937,000

May 5 (Reuters) - Optomed Plc  OPTOMED.HE :
    * OPTOMED PLC: INTERIM REPORT, JANUARY - MARCH 2022
    * Q1 REVENUE DECREASED BY 18.5 PERCENT TO EUR 3.2 (3.9)
MILLION
    * Q1 EBITDA AMOUNTED TO EUR -937 (-315) THOUSAND
    * MAIN REASON FOR THIS NEGATIVE TREND IN SALES WAS LOW
CAMERA
SALES TO CHINA COMPARED TO A RELATIVELY HIGH COMPARISON PERIOD
LAST YEAR
    * WAR IN UKRAINE IS CURRENTLY HAVING SOME NEGATIVE EFFECTS
ON
BUSINESS OF BOTH SEGMENTS
    * IMPACT OF WAR ON OUR FULL-YEAR REVENUE IS EXPECTED TO BE
RELATIVELY SMALL.

Source text for Eikon:  ID:nWkrVmlTy 
Further company coverage:  OPTOMED.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Optomed Oyj

See all news